Skip to main content
. 2013 Mar 7;15(2):R20. doi: 10.1186/bcr3395

Table 3.

Comparison between CK19 RT-qPCR, multiplex RT-qPCR and AdnaTest for the molecular characterization of CTC in breast cancer.

Multiplex RT-qPCR Singleplex RT-qPCR
AdnaTest/ CK19 HER-2 MAGE A3 CK19

Pos. Neg. Pos. Neg. Pos. Neg. Pos. Neg.

Early breast cancer, (number = 254)

GA733-2 Positive 1 8 0 9 0 9 2 7
Negative 24 221 28 217 12 233 34 211
Concordance (%) 87.4 Pa = 0.897 85.4 Pa = 0.284 91.7 Pa = 0.496 83.9 Pa = 0.481
MUC-1 Positive 0 14 1 13 0 14 1 13
Negative 24 215 27 213 12 228 35 205
Concordance (%) 84.6 Pa = 0.213 84.3 Pa = 0.633 89.8 Pa = 0.391 81.1 Pa = 0.438
HER-2 Positive 2 24 2 24 0 26 2 24
Negative 23 205 26 202 12 216 34 194
Concordance (%) 81.5 Pa = 0.698 80.3 Pa = 0.567 85 Pa = 0.231 77.2 Pa = 0.317

Verified metastasis, (number = 51)

GA733-2 Positive 14 6 6 14 3 17 15 5
Negative 4 27 2 29 1 30 6 25
Concordance (%) 80.4 Pb < 0.001 68.6 Pb = 0.045 64.7 Pb = 0.287 78.4 Pb = 0.000
MUC-1 Positive 14 9 6 17 3 20 14 9
Negative 4 24 2 26 1 27 7 21
Concordance (%) 74.5 Pb = 0.001 62.7 Pb = 0.119 58.8 Pb = 0.316 68.6 Pb = 0.012
HER-2 Positive 11 7 5 13 1 17 13 5
Negative 7 26 3 30 3 30 8 25
Concordance (%) 72.6 Pb = 0.006 68.6 Pb = 0.112 60.8 Pb = 1 74.5 Pb = 0.001

achi-square test; bFisher's exact test; P < 0.05 is considered as significant.